Victrex plc 28.7% potential upside indicated by Barclays

Broker Ratings

Victrex plc with ticker (LON:VCT) now has a potential upside of 28.7% according to Barclays.

Barclays set a target price of 2,190 GBX for the company, which when compared to the Victrex plc share price of 1,562 GBX at opening today (21/12/2022) indicates a potential upside of 28.7%. Trading has ranged between 1,522 (52 week low) and 2,502 (52 week high) with an average of 155,729 shares exchanging hands daily. The market capitalisation at the time of writing is £1,358,018,487.

Victrex plc is a United Kingdom-based company, which manufactures and sells polymers worldwide. The Company develops polyetheretherketone (PEEK) and PAEK polymer solutions, and semi-finished and finished parts. The Company also offers specialist solutions for medical device manufacturers; sells thermoplastic polymer components; and engages in trading activities. The Company operates through two segments: Industrial and Medical. The Industrial segment is focused on the Company’s energy and industrial, value-added resellers (VAR), automotive, aerospace and electronics markets. The Medical segment is focused on providing specialist solutions for medical device manufacturers. The Company’s subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component, Manufacturing Limited and Juvora Limited.

Find more news, interviews, share price & company profile here for:

    Good news travels fast (but only if you make that happen). Share on:


      AIM All Share Index